{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:09:55Z","timestamp":1778918995406,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Natural Science Research Projects of Higher Education Institutions in Anhui Province in 2024","award":["2024AH051278"],"award-info":[{"award-number":["2024AH051278"]}]},{"name":"Key Natural Science Research Projects of Higher Education Institutions in Anhui Province in 2023","award":["2023AH051942"],"award-info":[{"award-number":["2023AH051942"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05522-0","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:30:45Z","timestamp":1774603845000},"page":"2053-2062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP52 impedes malignant progression and cell stemness in prostate cancer by deubiquitinating RBM5 to down-regulate NCAPG2"],"prefix":"10.1007","volume":"481","author":[{"given":"Hongliang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"5522_CR1","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S (2022) Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules 27:5730. https:\/\/doi.org\/10.3390\/molecules27175730","journal-title":"Molecules"},{"key":"5522_CR2","doi-asserted-by":"publisher","first-page":"153303382412900","DOI":"10.1177\/15330338241290029","volume":"23","author":"P Agbetuyi-Tayo","year":"2024","unstructured":"Agbetuyi-Tayo P, Gbadebo M, Rotimi OA, Rotimi SO (2024) Advancements in Biomarkers of Prostate Cancer. Rev Technol cancer Res Treat 23:15330338241290029. https:\/\/doi.org\/10.1177\/15330338241290029","journal-title":"Rev Technol cancer Res Treat"},{"key":"5522_CR3","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee SY, Kim J (2022) Complexities of Prostate Cancer. Int J Mol Sci 23:14257. https:\/\/doi.org\/10.3390\/ijms232214257","journal-title":"Int J Mol Sci"},{"key":"5522_CR4","first-page":"24","volume":"27","author":"A Uhr","year":"2020","unstructured":"Uhr A, Glick L, Gomella LG (2020) An overview of biomarkers in the diagnosis and management of prostate cancer. Can J Urol 27:24\u201327","journal-title":"Can J Urol"},{"key":"5522_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, Jia X, Dong Z, Liu K (2024) Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer 23:148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3","journal-title":"Mol Cancer"},{"key":"5522_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"SM Lange","year":"2022","unstructured":"Lange SM, Armstrong LA, Kulathu Y (2022) Deubiquitinases: From mechanisms to their inhibition by small molecules. Mol Cell 82:15\u201329. https:\/\/doi.org\/10.1016\/j.molcel.2021.10.027","journal-title":"Mol Cell"},{"key":"5522_CR7","doi-asserted-by":"publisher","first-page":"e14799","DOI":"10.7717\/peerj.14799","volume":"11","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cui S, Chen Y, Guo S, Chen D (2023) Ubiquitin specific peptidases and prostate cancer. PeerJ 11:e14799. https:\/\/doi.org\/10.7717\/peerj.14799","journal-title":"PeerJ"},{"key":"5522_CR8","doi-asserted-by":"publisher","unstructured":"Liu J, Luo Y, Chen S, Wang G, Jin W, Jiang W, Li M, Wang Y, Yu J, Wei H, Zhang R, Zhou F, Ju L, Zhang Y, Xiao Y, Qian K, Wang X (2024) Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11\/xCT. https:\/\/doi.org\/10.1002\/advs.202403995. Adv Sci e2403995","DOI":"10.1002\/advs.202403995"},{"key":"5522_CR9","doi-asserted-by":"publisher","first-page":"BSR20210486","DOI":"10.1042\/BSR20210486","volume":"41","author":"M Zhu","year":"2021","unstructured":"Zhu M, Zhang H, Lu F, Wang Z, Wu Y, Chen H, Fan X, Yin Z, Liang F (2021) USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer. Biosci Rep 41:BSR20210486. https:\/\/doi.org\/10.1042\/BSR20210486","journal-title":"Biosci Rep"},{"key":"5522_CR10","doi-asserted-by":"publisher","first-page":"149703","DOI":"10.1016\/j.bbrc.2024.149703","volume":"704","author":"X Zhou","year":"2024","unstructured":"Zhou X, Cao Y, Li R, Di X, Wang Y, Wang K (2024) PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer. Biochem Biophys Res Commun 704:149703. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149703","journal-title":"Biochem Biophys Res Commun"},{"key":"5522_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1139\/bcb-2022-0048","volume":"100","author":"Z Feng","year":"2022","unstructured":"Feng Z, Zhang L, Liu Y, Zhang W (2022) NCAPG2 contributes to the progression of malignant melanoma through regulating proliferation and metastasis. Biochemistry and cell biology =. Biochimie et Biol cellulaire 100:473\u2013484. https:\/\/doi.org\/10.1139\/bcb-2022-0048","journal-title":"Biochimie et Biol cellulaire"},{"key":"5522_CR12","doi-asserted-by":"publisher","first-page":"e70985","DOI":"10.1002\/cam4.70985","volume":"14","author":"L Chen","year":"2025","unstructured":"Chen L, Lin Y, Lai Y, Li Y, Chen T, Luo X, Ye Y (2025) RPL35A Downregulation Suppresses Hepatocellular Carcinoma Cell Proliferation via NCAPG2 Inactivation. Cancer Med 14:e70985. https:\/\/doi.org\/10.1002\/cam4.70985","journal-title":"Cancer Med"},{"key":"5522_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12967-023-04834-9","volume":"22","author":"E Zhang","year":"2024","unstructured":"Zhang E, Chen Z, Liu W, Lin L, Wu L, Guan J, Wang J, Kong C, Bi J, Zhang M (2024) NCAPG2 promotes prostate cancer malignancy and stemness via STAT3\/c-MYC signaling. J translational Med 22:12. https:\/\/doi.org\/10.1186\/s12967-023-04834-9","journal-title":"J translational Med"},{"key":"5522_CR14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauss A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U (2020) Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol 11:1280. https:\/\/doi.org\/10.3389\/fimmu.2020.01280","journal-title":"Front Immunol"},{"key":"5522_CR15","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.21873\/anticanres.14559","volume":"40","author":"M Miyashita","year":"2020","unstructured":"Miyashita M, Tomogane M, Nakamura Y, Shimizu T, Fujihara A, Ukimura O, Ashihara E (2020) Sphere-derived Prostate Cancer Stem Cells Are Resistant to gammadelta T Cell Cytotoxicity. Anticancer Res 40:5481\u20135487. https:\/\/doi.org\/10.21873\/anticanres.14559","journal-title":"Anticancer Res"},{"key":"5522_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s11655-023-3595-2","volume":"29","author":"MH Wu","year":"2023","unstructured":"Wu MH, Wu K, Zhu YB, Li DC, Yang H, Zeng H (2023) Baicalin Antagonizes Prostate Cancer Stemness via Inhibiting Notch1\/NF-kappaB Signaling Pathway. Chin J Integr Med 29:914\u2013923. https:\/\/doi.org\/10.1007\/s11655-023-3595-2","journal-title":"Chin J Integr Med"},{"key":"5522_CR17","doi-asserted-by":"publisher","unstructured":"Geng L, Chen X, Zhang M, Luo Z (2020) Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2. Biochemical and biophysical research communications. 524:16\u201321. https:\/\/doi.org\/10.1016\/j.bbrc.2019.12.128","DOI":"10.1016\/j.bbrc.2019.12.128"},{"key":"5522_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14348\/molcells.2018.0329","volume":"42","author":"JM Park","year":"2019","unstructured":"Park JM, Lee JE, Park CM, Kim JH (2019) USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization. Mol Cells 42:17\u201327. https:\/\/doi.org\/10.14348\/molcells.2018.0329","journal-title":"Mol Cells"},{"key":"5522_CR19","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K (2019) Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 234:8381\u20138395. https:\/\/doi.org\/10.1002\/jcp.27740","journal-title":"J Cell Physiol"},{"key":"5522_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S (2024) Hallmarks of cancer stemness. Cell Stem Cell 31:617\u2013639. https:\/\/doi.org\/10.1016\/j.stem.2024.04.004","journal-title":"Cell Stem Cell"},{"key":"5522_CR21","doi-asserted-by":"publisher","first-page":"116319","DOI":"10.1016\/j.bcp.2024.116319","volume":"226","author":"H Yin","year":"2024","unstructured":"Yin H, Wu D, Qu Q, Li Z, Zhao L (2024) Ubiquitin-specific peptidase 15 regulates the TFAP4\/PCGF1 axis facilitating liver metastasis of colorectal cancer and cell stemness. Biochem Pharmacol 226:116319. https:\/\/doi.org\/10.1016\/j.bcp.2024.116319","journal-title":"Biochem Pharmacol"},{"key":"5522_CR22","doi-asserted-by":"publisher","unstructured":"Zhong B, Zhu Q, Wang L, Wang F, Zheng Y, Lin S, Cheng X (2023) USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC-3 and SW1990 cells. Cell biology international. 47:1368\u20131380. https:\/\/doi.org\/10.1002\/cbin.12024","DOI":"10.1002\/cbin.12024"},{"key":"5522_CR23","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/biomedicines10102413","volume":"10","author":"U Lendeckel","year":"2022","unstructured":"Lendeckel U, Wolke C (2022) Redox-Regulation in Cancer Stem Cells. Biomedicines 10:2413. https:\/\/doi.org\/10.3390\/biomedicines10102413","journal-title":"Biomedicines"},{"key":"5522_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s12967-023-04540-6","volume":"21","author":"K Niu","year":"2023","unstructured":"Niu K, Shi Y, Lv Q, Wang Y, Chen J, Zhang W, Feng K, Zhang Y (2023) Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms. J translational Med 21:665. https:\/\/doi.org\/10.1186\/s12967-023-04540-6","journal-title":"J translational Med"},{"key":"5522_CR25","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.celrep.2024.114917","volume":"43","author":"B Huang","year":"2024","unstructured":"Huang B, Cao D, Yuan X, Xiong Y, Chen B, Wang Y, Niu X, Tian R, Huang H (2024) USP7 deubiquitinates KRAS and promotes non-small cell lung cancer. Cell Rep 43:114917. https:\/\/doi.org\/10.1016\/j.celrep.2024.114917","journal-title":"Cell Rep"},{"key":"5522_CR26","doi-asserted-by":"publisher","first-page":"114284","DOI":"10.1016\/j.yexcr.2024.114284","volume":"442","author":"L Geng","year":"2024","unstructured":"Geng L, Liu F, Yang L, Liu Y, Wu G (2024) USP18 promotes the proliferation, invasion, and migration of head and neck squamous cell carcinoma by deubiquitinating PLK1. Exp Cell Res 442:114284. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114284","journal-title":"Exp Cell Res"},{"key":"5522_CR27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41467-018-03588-z","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Liu L, Cao C, Song N, Wang Y, Ma S, Zhang Q, Yu N, Ding X, Yang F, Tian S, Zhang K, Sun T, Yang J, Yao Z, Wu S, Shi L (2018) USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization. Nat Commun 9:1285. https:\/\/doi.org\/10.1038\/s41467-018-03588-z","journal-title":"Nat Commun"},{"key":"5522_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13059-023-03149-8","volume":"25","author":"M Zhang","year":"2024","unstructured":"Zhang M, Hyle J, Chen X, Xin Y, Jin Y, Zhang J, Yang X, Chen X, Wright S, Liu Z, Rosikiewicz W, Xu B, He L, Liu H, Ping N, Wu D, Wen F, Li C, Xu P (2024) RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome Biol 25:16. https:\/\/doi.org\/10.1186\/s13059-023-03149-8","journal-title":"Genome Biol"},{"key":"5522_CR29","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.4251\/wjgo.v16.i7.3241","volume":"16","author":"CX Wang","year":"2024","unstructured":"Wang CX, Liu F, Wang Y (2024) RBM5 suppresses proliferation, metastasis and glycolysis of colorectal cancer cells via stabilizing phosphatase and tensin homolog mRNA. World J Gastrointest Oncol 16:3241\u20133255. https:\/\/doi.org\/10.4251\/wjgo.v16.i7.3241","journal-title":"World J Gastrointest Oncol"},{"key":"5522_CR30","doi-asserted-by":"publisher","first-page":"110844","DOI":"10.1016\/j.cellsig.2023.110844","volume":"110","author":"S Han","year":"2023","unstructured":"Han S, Jin X, Hu T, Chi F (2023) The mRNA stability of NCAPG2, a novel contributor to breast invasive carcinoma, is enhanced by the RNA-binding protein PCBP2. Cell Signal 110:110844. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110844","journal-title":"Cell Signal"},{"key":"5522_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00441-020-03281-y","volume":"383","author":"J Wu","year":"2021","unstructured":"Wu J, Li L, Jiang G, Zhan H, Zhu X, Yang W (2021) NCAPG2 facilitates glioblastoma cells\u2019 malignancy and xenograft tumor growth via HBO1 activation by phosphorylation. Cell Tissue Res 383:693\u2013706. https:\/\/doi.org\/10.1007\/s00441-020-03281-y","journal-title":"Cell Tissue Res"},{"key":"5522_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/jcmm.13010","volume":"21","author":"P Zhan","year":"2017","unstructured":"Zhan P, Xi GM, Zhang B, Wu Y, Liu HB, Liu YF, Xu WJ, Zhu Q, Cai F, Zhou ZJ, Miu YY, Wang XX, Jin JJ, Li Q, Lv TF, Song Y (2017) NCAPG2 promotes tumour proliferation by regulating G2\/M phase and associates with poor prognosis in lung adenocarcinoma. J Cell Mol Med 21:665\u2013676. https:\/\/doi.org\/10.1111\/jcmm.13010","journal-title":"J Cell Mol Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05522-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05522-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05522-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:40Z","timestamp":1778916520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05522-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5522"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05522-0","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the ethical review committee of The First Affiliated Hospital of Bengbu Medical University with approval No.20250218. Written informed consent was obtained from all enrolled patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients agree to participate in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}